Skip to main content
TipRanks
Go Ultimate75% OFF

Terry Gould Insider Profile

4 Followers

Terry Gould, Director, Ten Percent Owner at Corvus Pharmaceuticals, holds 256.78K shares in Icosavax (Ticker: ICVX), holds 1.81M shares in Aptinyx (Ticker: APTX), holds 3.28M shares in Corvus Pharmaceuticals (Ticker: CRVS).

Terry Gould's Trading History

ICVX
Icosavax
Aug 03, 2021―Uninformative Buy―$3.93M
APTX
Aptinyx
Jun 26, 2018―Uninformative Buy―$173.88K
CRVS
Corvus Pharmaceuticals
Mar 13, 2018Director, Ten Percent OwnerInformative Buy5.00M$34.85M
OMED
OncoMed Pharma
Dec 02, 2015―Uninformative Buy―$1.15M

You May Also Like

Terry Gould insider profile FAQ

What is the percentage of profitable transactions made by Terry Gould?
The percentage of profitable transactions made by Terry Gould is 0%.
What is the average return per transaction made by Terry Gould?
The average return per transaction made by Terry Gould is -72.80%.
What stocks does Terry Gould hold?
Terry Gould holds: CRVS, OMED, APTX, ICVX stocks.
What was Terry Gould's most profitable transaction?
Terry Gould’s most profitable transaction was an Informative Buy of CRVS stock on March 13, 2018. The return on the trade was -60.20%.
What is Terry Gould's role in Corvus Pharmaceuticals?
Terry Gould's role in Corvus Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.